On the will to ignorance in bureaucracy
On the will to ignorance in bureaucracy
复制标题
DOI：
10.1080/03085140701254282
复制
发表时间：
2007-01-01
影响因子：
3.4
通讯作者：
McGoey, Linsey
中科院分区：
文献类型：
--
作者：
McGoey, Linsey
通过对英国精神病学家和健康分析师的叙述性采访，这篇文章提供了对诸如百忧解和赛乐特等SSRI类抗抑郁药安全性的争论的分析。这篇文章的重点是我所描述的，利用福柯、尼采、尼古拉斯·卢曼和迈克尔·鲍尔的观点，在监管官僚机构中存在一种“无知的意志”，这种意志旨在规避监管机构实现其明确目的和目标的能力。在描述了影响患者和从业人员就抗抑郁药的风险和益处得出结论的监管过程之后，我最后建议，本文对SSRIs监管的分析为一般监管和官僚主义的研究提供了理论见解。
Drawing on narrative interviews with psychiatrists and health analysts in Britain, the article provides an analysis of debates over the safety of SSRI antidepressants such as Prozac and Seroxat. The focus of the article is on what I describe, drawing on Foucault, Nietzsche, Niklas Luhmann and Michael Power, as a 'will to ignorance' within regulatory bureaucracies which works to circumvent a regulator's ability to carry out its explicit aims and goals. After a description of the regulatory processes that have influenced the efforts of patients and practitioners to reach conclusions on the risks and benefits of antidepressants, I conclude by suggesting that the article's analysis of the regulation of SSRIs carries theoretical insights for the study of regulation and bureaucracy in general.